Results 161 to 170 of about 13,707 (310)

Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma [PDF]

open access: bronze, 2020
G d’Ancona   +9 more
openalex   +1 more source

Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE

open access: yesJournal of Allergy and Clinical Immunology: Global
Background: In the phase III SYNAPSE study, mepolizumab plus standard of care reduced total endoscopic nasal polyp score (NPS) versus that with placebo in patients with chronic rhinosinusitis with nasal polyps.
Amber U. Luong, MD, PhD   +8 more
doaj  

When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation [PDF]

open access: bronze, 2019
Diego Bagnasco   +8 more
openalex   +1 more source

Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma [PDF]

open access: hybrid, 2020
Joanne Kavanagh   +10 more
openalex   +1 more source

Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome

open access: bronze, 2010
Florence Roufosse   +10 more
openalex   +1 more source

Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma [PDF]

open access: bronze, 2019
Frank C. Albers   +7 more
openalex   +1 more source

When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report

open access: yesJournal of Medical Case Reports
Background The advent of biologics has resulted in major progress in the treatment of severe T2 high asthmatics. There are currently several classes of biologics approved for severe asthma including anti-immunoglobulin E, anti-interleukin-5/interleukin ...
M. Sabbe   +3 more
doaj   +1 more source

Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study [PDF]

open access: gold, 2020
Giovanna Elisiana Carpagnano   +10 more
openalex   +1 more source

Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab [PDF]

open access: gold, 2019
Nobuhiro Matsumoto   +5 more
openalex   +1 more source

The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study [PDF]

open access: green, 2021
P. Jane McDowell   +42 more
openalex   +1 more source

Home - About - Disclaimer - Privacy